Tendamistat as a scaffold for conformationally constrained phage peptide libraries

Journal of Molecular Biology
S J McConnell, R H Hoess

Abstract

The alpha-amylase inhibitor Tendamistat (Hoe-467), a 74 amino acid beta-sheet protein from Streptomyces tendae has been expressed on the surface of the filamentous bacteriophage M13. Phage displaying Tendamistat inhibit the hydrolysis of starch by alpha-amylase, indicating that the displayed protein is functional. The displayed Tendamistat has been used as a molecular scaffold for the presentation of constrained random peptides. Two loops, comprising residues 38 to 40 and 60 to 65 of Tendamistat, were randomized using PCR mutagenesis. Libraries of approximately 10(8) different mutant Tendamistat molecules were tested for binding to monoclonal antibody A8, which recognizes endothelin. After three cycles of biopanning, phage were isolated that specifically bound the monoclonal antibody. Loop swapping and alanine replacement mutagenesis indicated that residues in the 60 to 65 loop are responsible for binding to the monoclonal antibody. This work demonstrates the use of relatively small non-antibody protein scaffolds for the presentation of constrained random peptide sequences to select for novel binding molecules.

Citations

Oct 8, 2005·Nature Biotechnology·H Kaspar BinzAndreas Plückthun
Nov 11, 1999·Protein Engineering·E GunneriussonP Nygren
Aug 31, 2000·Protein Engineering·V A Petrenko, G P Smith
Nov 20, 1998·Biological Chemistry·S J McConnellD G Spinella
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·B A CohenR Brent
Jul 8, 2011·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Fernando PorcelliGianluigi Veglia
Jun 15, 2005·Expert Opinion on Biological Therapy·Corina BorghoutsBernd Groner
Jul 6, 2004·Journal of Microbiological Methods·Valery A Petrenko, Iryna B Sorokulova
Jul 21, 2004·Journal of Immunological Methods·Per-Ake Nygren, Arne Skerra
Oct 20, 2005·Journal of Bioscience and Bioengineering·Fumiaki UchiyamaNoritaka Tokui
Jul 3, 2015·Molecular BioSystems·Hannah F KyleThomas A Edwards
Dec 10, 1999·Protein Engineering·F MartinM Sollazzo
Mar 1, 1997·Nature Biotechnology·S Brown
Mar 17, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Frederic ZollerWalter Mier
May 1, 1996·Molecular Diversity·S J McConnellD G Spinella
Jun 15, 2005·Angewandte Chemie·Hang Yin, Andrew D Hamilton
Sep 3, 2005·Journal of Peptide Science : an Official Publication of the European Peptide Society·Corina BorghoutsBernd Groner
Mar 1, 2003·Nature Genetics·Scott D Patterson, Ruedi H Aebersold
Jul 23, 1998·Canadian Journal of Microbiology·D R Wilson, B B Finlay
Aug 10, 2000·Journal of Molecular Recognition : JMR·A Skerra
Nov 10, 2005·Chemical Reviews·John W Kehoe, Brian K Kay
Jun 6, 1998·Journal of Molecular Biology·G P SmithA D Griffiths
Oct 1, 1996·Current Opinion in Biotechnology·I S Dunn
Sep 1, 2000·Advanced Drug Delivery Reviews·F NilssonD Neri
Sep 22, 2001·The Journal of Steroid Biochemistry and Molecular Biology·F Hoppe-SeylerK Butz
Jul 14, 1998·Immunotechnology : an International Journal of Immunological Engineering·H R HoogenboomR C Roovers
Sep 3, 2002·Chemistry & Biology·Lihui XuDasa Lipovsek
Nov 17, 2001·Chemical Reviews·R H Hoess
Oct 26, 2005·Journal of Chromatography. a·Yannis D Clonis
Apr 1, 1997·Chemical Reviews·George P. Smith, Valery A. Petrenko
Jun 18, 2014·Journal of Chemical Information and Modeling·Sathish Kumar RamakrishnanCsilla Gergely
Jan 21, 2004·Biochemistry·Tania DottoriniMaurizio Sollazzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.